Freya Biosciences
Biotechnology

Freya Biosciences: Products & infrastructure

Freya Biosciences has 5 clinical trials on record, 2 under way.

Data updated Nov 20, 2026 · Back to the company report

Products

Freya Biosciences has 5 clinical trials on record, 2 under way.

5clinical trials
2trials under way
2EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
Open-label safety and efficacy trial of chlorhexidine and/or metronidazole pre-treatment followed by FB301 in women wit…
Therapeutic exploratory (Phase II) · Bacterial vaginosis · Germany
Feb 2026
Phase 1 first-in-human, single and multiple dosing study of FB301 in healthy female subjects
Human Pharmacology (Phase I)- First administration to humans · Women infertility · Germany
Feb 2025
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embr…
phase 2 · under way · 30 participants · Vaginal Dysbiosis
Jul 2026
Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial
phase 2 · under way · 120 participants · Bacterial Vaginosis (BV)
Mar 2026
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)
completed · 97 participants · Vaginal Flora Imbalance
May 2023
Vaginal Microbiome and IVF Pregnancy Outcome
completed · 301 participants · Vaginal Flora Imbalance
Mar 2022
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis
completed · 34 participants · Vaginal Flora Imbalance
Oct 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.